The European Molecular Biology Organization (EMBO) announced today the introduction of a new private pension plan for EMBO Fellows. The plan offers a benefit package that optimally suits the needs of highly mobile scientists.
Post-doctoral researchers who are beneficiaries of an EMBO Long-Term Fellowship may begin enrolling in the pension plan from 1 January 2010.
"The international portability of the pension plan allows contributors to continue in the plan as they move from country to country," said Jan Taplick, EMBO Deputy Director and manager of EMBO Fellowships. "We are pleased to now offer a solution to the long-time problem facing EMBO Fellows who wish to plan for financial security while they are actively mobile early in their research careers."
Renowned for strict attention to scientific excellence, EMBO Fellowships have supported thousands of talented young researchers since they were first introduced in the 1960s. More than 200 long-term fellowships are awarded annually, offering funding and support for two-year post-doctoral research terms.
This is the first time that a European science organization has established a pension plan for its fellows. MLP, a Heidelberg based independent financial services and wealth management consulting company, has developed the concept and will also administer the pension plan according to the needs of highly mobile scientists. Funds invested in the plan will be managed by Allianz, one of the highest-rated worldwide insurers operating in more than seventy countries.
"The pension plan is a unique concept that has been tailored to the requirements of EMBO Fellows," said Harald Huhn, Managing Director of the Company Pension Scheme Division at MLP. "It allows them to make early pension provisions without having to make any concessions in terms of their mobility."
Following completion of PhD studies, many young researchers often take up post-doctoral research positions in laboratories outside their home countries. It's not unusual for them to move two, or even three, times in the early years of their careers to benefit from exchange with experienced researchers in their chosen fields. Generally this has meant delaying planning for financial security later in life until they take up permanent positions.
A survey conducted by the EMBO Fellowship office revealed that less than ten per cent of fellows contributed to a pension scheme, while nearly all of them were insured against health risks and accidents. The European Charter for Researchers, released by the European Commission (EC) in 2005, called for "adequate and equitable social security provisions" as a basic entitlement for researchers.
A recent decision by the EC to co-fund EMBO Long-Term Fellowships commended the anticipated introduction of the private pension plan for awardees of the fellowships. The 4.3 million euro EC funding will allow EMBO to award 35 percent more long-term fellowships annually - between 75 and 80 additional long-term fellowships. Co-funded EMBO Fellows will be selected during the next two evaluation rounds, making them eligible to participate in the new pension plan.
All new and second-year EMBO Fellows will have the opportunity to join the pension plan when it begins in January 2010. EMBC, the EMBO intergovernmental funding body, is contributing additional funding to support the international mobility of early-stage researchers. The EMBC support allows for incentive contributions of 100 euro per month during a two-year fellowship for each EMBO Fellow enrolled in the plan. Participation in the pension plan is voluntary.
In addition to the monthly 100-euro incentive, participants in the pension plan benefit from:Attractive group conditions
Annual EMBO Long-Term Fellowships application deadlines: 15 August & 15 February.About EMBO
Leading peer-reviewed journals - The EMBO Journal, EMBO reports and Molecular Systems Biology - span a broad spectrum of topics of molecular biology and reflect how science is shaping the world. A new journal, EMBO Molecular Medicine, publishes original research offering molecular insight into the cellular and systemic processes underlying human disease.
EMBO funding, training and networking activities impact thousands of scientists every year, promoting collaboration in all areas of molecular biology - within its 27 member states, in Europe and neighbouring countries, and worldwide.
Suzanne Beveridge | idw
Historical rainfall levels are significant in carbon emissions from soil
30.05.2017 | University of Texas at Austin
3D printer inks from the woods
30.05.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt
Scientists have developed a new method of characterizing graphene’s properties without applying disruptive electrical contacts, allowing them to investigate both the resistance and quantum capacitance of graphene and other two-dimensional materials. Researchers from the Swiss Nanoscience Institute and the University of Basel’s Department of Physics reported their findings in the journal Physical Review Applied.
Graphene consists of a single layer of carbon atoms. It is transparent, harder than diamond and stronger than steel, yet flexible, and a significantly better...
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
30.05.2017 | Life Sciences
30.05.2017 | Life Sciences
30.05.2017 | Physics and Astronomy